Maintaining cold chain equipment safety for vaccines
Our expertise in product safety and performance testing helps to mitigate risk and accelerate getting refrigerated medical and vaccine solutions to market. Our offerings cover critical needs including process auditing, performance material validation, chain of custody, chain of condition, cybersecurity, sanitation, electromagnetic compatibility (EMC) and wireless services.
While promising new vaccines will hopefully end the coronavirus pandemic, some of these pharmaceutical products pose new logistical challenges for manufacturers, transporters, warehousers and end users. Processes to maintain the uninterrupted series of refrigerated production, storage and distribution activities, along with associated equipment and logistics, which maintain a desired low-temperature range are known as a “cold chain.” Drug compound integrity must be preserved from manufacturing plant departure all the way through the cold chain to the intended patients. This process often involves packaging with dry ice or liquid nitrogen and the use of specialty freezers and refrigeration units.
UL Solutions’ decades of advanced technical, regulatory and clinical expertise are reflected in our refrigeration testing innovation. This allows us to help customers manage regulatory and global market access issues and address emerging connected device risks. We help confirm that medical and vaccine storage equipment is safe to deploy for use in an increasingly patient-centric and connected environment, as well as support clients in solving critical health, safety, security, and interoperability challenges.